General Information of the Compound
| Compound ID |
CP0433005
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(7E)-5-(3-amino-3-oxopropanoyl)-1-(2,4-dichlorophenyl)-7-[(4-fluorophenyl)methylidene]-N-[(1R)-1-pyridin-2-ylethyl]-4,6-dihydropyrazolo[4,3-c]pyridine-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H25Cl2FN6O3
|
||||||||||||||||||
| Molecular Weight |
607.473
|
||||||||||||||||||
| Canonical SMILES |
C[C@@H](NC(=O)c1nn(c2c1CN(C\C2=C/c1ccc(F)cc1)C(=O)CC(N)=O)-c1ccc(Cl)cc1Cl)c1ccccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H25Cl2FN6O3/c1-17(24-4-2-3-11-35-24)36-30(42)28-22-16-38(27(41)14-26(34)40)15-19(12-18-5-8-21(33)9-6-18)29(22)39(37-28)25-10-7-20(31)13-23(25)32/h2-13,17H,14-16H2,1H3,(H2,34,40)(H,36,42)/b19-12+/t17-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UVZIHKAXDURETI-MIQLPHMESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Protein ID: PT00834, Cannabinoid receptor 2